LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 48 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -20.0% | 23,272 | +57.7% | 0.00% | – |
| Q1 2022 | $10,000 | -91.4% | 14,755 | -70.4% | 0.00% | – |
| Q4 2021 | $116,000 | -45.0% | 49,828 | +7.9% | 0.00% | – |
| Q3 2021 | $211,000 | +67.5% | 46,175 | +62.7% | 0.00% | – |
| Q2 2021 | $126,000 | -13.7% | 28,384 | +101.8% | 0.00% | – |
| Q4 2018 | $146,000 | – | 14,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,220,000 | 0.38% |
| Orbimed Advisors | 8,466,783 | $37,593,000 | 0.38% |
| Sio Capital Management, LLC | 182,630 | $811,000 | 0.20% |
| Tibra Equities Europe Ltd | 76,500 | $340,000 | 0.10% |
| SAMLYN CAPITAL, LLC | 1,420,452 | $6,308,000 | 0.09% |
| PURA VIDA INVESTMENTS, LLC | 249,256 | $1,107,000 | 0.03% |
| Trexquant Investment LP | 46,229 | $205,000 | 0.02% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $67,000 | 0.01% |
| Baker Brothers Advisors | 451,478 | $2,005,000 | 0.01% |
| Verition Fund Management LLC | 208,099 | $924,000 | 0.01% |